Guangshun Yi

Our laboratory focuses on developing innovative solutions to combat antimicrobial resistance (AMR). Our main research themes include antimicrobial nanomedicines, bacteriophage therapy, and antimicrobial peptides aimed at treating infections caused by drug resistant pathogens. Using advanced materials engineering, molecular microbiology, and in vitro and in vivo infection models, we work to create next generation therapeutics that address one of the most urgent global health threats. Beyond antimicrobials, we also develop MRI contrast agents and safe, flexible zinc ion batteries for wearable biomedical devices. These technologies are designed to improve diagnostic accuracy and enable continuous health monitoring. Our long term goal is to deliver clinically meaningful innovations that reduce AMR related mortality and strengthen KFSHRC’s leadership in patient centered medical research.